These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24700048)

  • 1. Auditory hallucinations induced by trazodone.
    Shiotsuki I; Terao T; Ishii N; Hatano K
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24700048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual and auditory hallucinations during normal use of paroxetine for treatment of major depressive disorder.
    Monji A; Kato T; Mizoguchi Y; Horikawa H; Seki Y; Kanba S
    J Neuropsychiatry Clin Neurosci; 2011; 23(4):E14-5. PubMed ID: 22231326
    [No Abstract]   [Full Text] [Related]  

  • 3. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

  • 4. Hallucination induced by paroxetine discontinuation in patients with major depressive disorders.
    Yasui-Furukori N; Kaneko S
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):384-5. PubMed ID: 21489048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute dystonic reaction with trazodone.
    Tesler-Mabe CS
    Can J Psychiatry; 1998 Dec; 43(10):1053. PubMed ID: 9868576
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose-trazodone-induced disorganized type psychosis.
    Mizoguchi Y; Monji A
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):253-4. PubMed ID: 15939985
    [No Abstract]   [Full Text] [Related]  

  • 7. Occurrence of trazodone-induced delirium.
    Lennkh C; Fischer P; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Sep; 13(5):225-8. PubMed ID: 9817628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable interaction between trazodone and carbamazepine.
    Sánchez-Romero A; Mayordomo-Aranda A; García-Delgado R; Durán-Quintana JA
    Pharmacopsychiatry; 2011 Jun; 44(4):158-9. PubMed ID: 21710406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tactile hallucinations associated with therapeutic doses of bupropion in 2 patients.
    Charuvastra A; Yaeger D
    J Clin Psychiatry; 2006 Nov; 67(11):1820-1. PubMed ID: 17196068
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lasting change in trazodone response after non-convulsive electroshock therapy for medication-resistant senile depression.
    Shen H; Awata S; Konno M; Sato M
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):111-3. PubMed ID: 9682943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
    Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
    Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction.
    Kito S; Koga Y
    Int Psychogeriatr; 2006 Dec; 18(4):749-51. PubMed ID: 17026779
    [No Abstract]   [Full Text] [Related]  

  • 14. A hemodialysis patient with trazodone-induced parkinsonism.
    Fukunishi I; Kitaoka T; Shirai T; Kino K; Kanematsu E; Sato Y
    Nephron; 2002 Feb; 90(2):222-3. PubMed ID: 11818711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of prolonged-release trazodone in major depressive disorder: a multicenter, randomized, double-blind, flexible-dose trial.
    Zhang L; Xie WW; Li LH; Zhang HG; Wang G; Chen DC; Cao Y; Cui LJ; Zhang KR; Shi JG; Tan QR; Zheng HB; Xu XF; Cheng ZH; Zhao JP
    Pharmacology; 2014; 94(5-6):199-206. PubMed ID: 25376160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of once-daily controlled-release trazodone for depressed mood, anxiety, insomnia, and suicidality in major depressive disorder.
    Sheehan DV; Rozova A; Gossen ER; Gibertini M
    Psychopharmacol Bull; 2009; 42(4):5-22. PubMed ID: 20581790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trazodone-induced priapism].
    Correas Gómez MA; Portillo Martín JA; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; del Valle Schaan JI; Roca Edreira A; Rado Velázquez MA; Hernández Castrillo A
    Actas Urol Esp; 2000; 24(10):840-2. PubMed ID: 11199305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between trazodone and carbamazepine.
    Romero AS; Delgado RG; Peña MF
    Ann Pharmacother; 1999 Dec; 33(12):1370. PubMed ID: 10630840
    [No Abstract]   [Full Text] [Related]  

  • 19. Trazodone-induced delirium in bulimic patients.
    Damlouji NF; Ferguson JM
    Am J Psychiatry; 1984 Mar; 141(3):434-5. PubMed ID: 6584039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
    Fagiolini A; Amodeo G; Goracci A; Blardi P
    Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.